Zevra Therapeutics (ZVRA) Net Equity Issued and Repurchased (2018 - 2024)
Zevra Therapeutics' (ZVRA) quarterly Net Equity Issued and Repurchased came in at $63.4 million in Q3 2024, up 89353.52% on a QoQ basis from -$71000.0 in Q2 2024.
Powered by 
Analysis
Zevra Therapeutics (ZVRA) Net Equity Issued and Repurchased (2018 - 2024) Analysis & Trends
Zevra Therapeutics (ZVRA) has 3 years of Net Equity Issued and Repurchased data on file, last reported at $63.4 million in Q3 2024.
- Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to $63.4 million in Q3 2024, while the trailing twelve-month figure through Dec 2025 was $63.4 million (down 1.78% YoY) and the FY2024 annual result came in at $64.5 million, up 956.6% from the prior year.
- Net Equity Issued and Repurchased grew to $63.4 million in Q3 2024, from -$71000.0 in the prior quarter.
- In the past five years, Net Equity Issued and Repurchased ranged from a high of $63.4 million in Q3 2024 to a low of -$71000.0 in Q2 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 49.20 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 141.90 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Zevra Therapeutics | 734.60 Mn | 513.03 Mn | 38.18 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2024 | 63.37 Mn |
| Jun 30, 2024 | -71,000.00 |
| Mar 31, 2024 | 1.22 Mn |
| Dec 31, 2023 | 6.11 Mn |
| Sep 30, 2018 | 836,000.00 |
| Jun 30, 2018 | 1.19 Mn |
| Mar 31, 2018 | 2.80 Mn |